Connected Medical Affairs

Business transformation through innovative technologies

  • Publication
  • July 30, 2024

Medical Affairs has come a long way since its inception as a support function to provide scientific information to Healthcare Professionals (HCPs) and answer queries related to usage of in-market drugs – it now unlocks value across the organization as a key strategic function of the biopharmaceutical organization. Medical Affairs leaders are expected to own areas that raise organizational performance and demonstrate impact, with the primary value proposition defined by three focus areas (3Es) that combine improved stakeholder experiences and treatment outcomes.

Informative chart

Technology - the catalyst for transformation

Technological advancements and the growth of scientific information are driving the continued transformation of Medical Affairs. Digitization is transforming healthcare delivery and influencing patient expectations. Additionally, the shift towards personalized treatment has necessitated a reassessment of engagement strategies with healthcare decision-makers.

Leaders in Medical Affairs are collaborating with strategic partners to explore innovations that can revolutionize evidence generation, stakeholder engagement, and medical education. This involves harnessing artificial intelligence (AI), advanced analytics, and visualization tools to drive transformative outcomes.

Examples of key technological innovations poised to drive the business transformation of the Medical Affairs function, enabling higher efficiency and better outcomes:

  • Data Integration of cloud-based platforms, artificial intelligence, and thorough data management strategies
  • Plain language summarization of scientific publications, clinical trial protocols, treatment guidelines, and other documents using generative AI algorithms
  • Sentiment analysis and influence network analytics
  • Global content management

Identifying technological hurdles

The promise of technology is alluring and has the potential to increase efficiencies and increase the impact of Medical Affairs. However, Medical Affairs leaders face multiple challenges in achieving success.

Each organization is unique, and available solutions often fail to meet the specific needs of Medical Affairs. The complexities of each business, both at the global and regional levels, often necessitate tailored solutions using technologies that are unfamiliar or unproven to Medical Affairs. This underscores the importance of supplementing in-house medical and technology knowledge and capabilities with external expertise.

Innovative technologies are, by definition, new, and can be perceived as unproven and not appropriate for use in Medical Affairs. Organizations should encourage upskilling to make full use of technology and provide opportunities to understand the value of technology in Medical Affairs.

When it comes to real world evidence (RWE), challenges include a limited understanding of how RWE is used across the product lifecycle, a lack of analytics experience to extract valuable insights from RWE, and a lack of an appropriate technology platform to host RWE.

Newer technologies like generative AI lack regulatory precedents; additionally, compliance guidelines regarding digital medical engagement remain unclear. To realize technology’s potential more fully, Medical Affairs should be flexible to adapt to evolving regulations and industry standards on tools and technologies.

The proliferation of data sources for insights has the opportunity to transform patient care. However, disjointed technology solutions that fail to meet the complex needs of Medical Affairs, coupled with the inability to efficiently integrate and analyze the data, can hinder progress. Organizations should invest in building data integration capabilities to fully realize their data’s potential.

Taking a strategic approach to overcoming challenges

In the face of emerging challenges, Medical Affairs should adopt a proactive strategy. This involves defining a vision, identifying, and prioritizing opportunities, planning, collaborating, and then implementing fit-to-purpose solutions. To enable sustainability, it is also critical to upskill the workforce and manage the change.

Informative chart

Selecting impactful use cases

As with any transformation, it is critical to consider expected value and return on investment (ROI). Medical Affairs leaders should think in a structured way about how technology brings value and ROI to the business and select applications of technology in Medical Affairs–i.e., use cases–accordingly.

Examples of use cases for technology in Medical Affairs:

A solution which facilitates the end-to-end insights workflow, from raw insight to tangible business outcome.

A solution that allows for targeted and efficient searches across scientific literature.

A solution that enables Medical leaders to track real-time performance of their function.

An end-to-end solution that enables the efficient entry and response to medical information inquiries.

A solution that provides access to approved medical content and tracks usage and effectiveness.

Embracing technology is non-negotiable

Medical Affairs has evolved to become a strategic function in the biopharmaceutical industry, focusing on Evidence, Engagement, and Education (3Es). It provides critical knowledge to biopharmaceutical leadership in anticipating shifts in the healthcare landscape, assessing competitors’ development pipelines, and suggesting extended therapeutic and digital health solutions. Its role is amplified by global trends such as complex therapies, digitization, and data proliferation.

Embracing technology can help Medical Affairs adapt to this transformation, with leaders exploring innovative use cases using advanced analytics and emerging technologies such as generative AI. However, mature organizations face unique challenges in this transformation, including shifting priorities, tight budgets, complex operating models, and difficulties in evidence aggregation.

Addressing these challenges is crucial and requires a proactive strategy and a diagnostic process – from the discovery of use cases, methodical planning, and collaboration, selecting the appropriate use cases, to implementing technology enabled solutions and enabling adoption. Effective change management and upskilling the workforce are key contributors to the transformation, and ultimately drivers of value realization.

Connected Medical Affairs: Business transformation through innovative technologies

Download full PDF (PDF of 2.43mb)

Contact us

Matthew Rich

Matthew Rich

Principal, Pharma & Life Sciences Cloud & Digital Leader, PwC US

Jean-Marc Neimetz

Jean-Marc Neimetz

Principal, Customer Transformation Leader, PwC US

Keith Morris

Keith Morris

Managing Director, Global Medical Affairs Transformation Leader, PwC US

Rachel Mercado

Rachel Mercado

Director, Pharma & Life Sciences Cloud & Digital, PwC US

Follow us